These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11893233)

  • 61. The natural history of benign prostatic hyperplasia.
    Fitzpatrick JM
    BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Prostatic benign hypertrophy: review of effectiveness, tolerance, and impact on quality of life of prolonged treatment with alfuzosin].
    Vela Navarrete R; Gabriel R; Barajas R; Ausín I
    Actas Urol Esp; 2000 Feb; 24(2):120-30. PubMed ID: 10829442
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety, efficacy and impact on Patients' quality of life of a long-term treatment with the alpha(1)-blocker alfuzosin in symptomatic patients with BPH. The Italian Alfuzosin Co-Operative Group.
    Eur Urol; 2000 Jun; 37(6):680-6. PubMed ID: 10828668
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multicenter observational trial on symptomatic treatment of benign prostatic hyperplasia with alfuzosin: clinical evaluation of impact on patient's quality of life. The Italian Alfuzosin Cooperative Group.
    Eur Urol; 1995; 27(2):128-34. PubMed ID: 7538083
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia.
    Grasso M; Montesano A; Buonaguidi A; Castelli M; Lania C; Rigatti P; Rocco F; Cesana BM; Borghi C
    Arch Esp Urol; 1995; 48(1):97-103. PubMed ID: 7537488
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Alpha-blocking treatment with alfuzosin in symptomatic benign prostatic hyperplasia: comparative study with prazosin. The PRAZALF Group.
    Buzelin JM; Hebert M; Blondin P
    Br J Urol; 1993 Dec; 72(6):922-7. PubMed ID: 7508331
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.
    Martorana G; Giberti C; Di Silverio F; von Heland M; Rigatti P; Colombo R; Casadei G; Pacifico P
    Eur Urol; 1997; 32(1):47-53. PubMed ID: 9266231
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical uroselectivity: a 3-year follow-up in general practice. BPH Group in General Practice.
    Lukacs B; Grange JC; McCarthy C; Comet D
    Eur Urol; 1998; 33 Suppl 2():28-33. PubMed ID: 9556193
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A clinical trial of the treatment of patients with benign prostatic hyperplasia using the alpha 1-adrenoblocker alfuzosin].
    Lopatkin NA; Perepanova TS
    Urol Nefrol (Mosk); 1997; (5):14-6. PubMed ID: 9412005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.
    Lukacs B; Leplège A; Thibault P; Jardin A
    Urology; 1996 Nov; 48(5):731-40. PubMed ID: 8911517
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand.
    Leungwattanakij S; Watanachote D; Noppakulsatit P; Petchpaibuol T; Choeypunt N; Tongbai T; Wanamkang T; Lojanapiwat B; Permpongkosol S; Tantiwong A; Pripatnanont C; Akarasakul D; Kongwiwatanakul S; Chotikawanich E
    J Sex Med; 2010 Sep; 7(9):3115-26. PubMed ID: 20233288
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alpha-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia.
    Cooper KL; McKiernan JM; Kaplan SA
    Drugs; 1999 Jan; 57(1):9-17. PubMed ID: 9951948
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.
    McNeill SA; Hargreave TB; Geffriaud-Ricouard C; Santoni J; Roehrborn CG
    Urology; 2001 Mar; 57(3):459-65. PubMed ID: 11248620
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparative study on the safety and efficacy of tamsulosin and alfuzosin in the management of symptomatic benign prostatic hyperplasia: a randomized controlled clinical trial.
    Lapitan MC; Acepcion V; Mangubat J
    J Int Med Res; 2005; 33(5):562-73. PubMed ID: 16222890
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Three months' treatment with the alpha1-blocker alfuzosin does not affect total or transition zone volume of the prostate.
    Roehrborn CG
    Prostate Cancer Prostatic Dis; 2006; 9(2):121-5. PubMed ID: 16304557
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Benign prostatic hyperplasia. Practical treatment guidelines.
    Tammela T
    Drugs Aging; 1997 May; 10(5):349-66. PubMed ID: 9143856
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia.
    Goldsmith DR; Plosker GL
    Drugs; 2005; 65(14):2037-47. PubMed ID: 16162024
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.
    Nickel JC; Elhilali M; Emberton M; Vallancien G;
    BJU Int; 2006 Jun; 97(6):1242-6. PubMed ID: 16686719
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Belgian multicenter clinical study of alfuzosin, a selective alpha 1-blocker, in the treatment of benign prostatic hyperplasia. The Alfuzosin Belgian Group.
    Schulman CC; De Sy W; Vandendris M; Tomas M; Santoni JP
    Acta Urol Belg; 1994 Dec; 62(4):15-21. PubMed ID: 7540794
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tamsulosin: an update of its role in the management of lower urinary tract symptoms.
    Lyseng-Williamson KA; Jarvis B; Wagstaff AJ
    Drugs; 2002; 62(1):135-67. PubMed ID: 11790159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.